Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction.
暂无分享,去创建一个
K. Kent | A. Pichard | L. Satler | R. Torguson | R. Waksman | D. Steinberg | Teruo Okabe | W. Suddath | P. Roy | T. L. P. Slottow | A. Buch | A. Javaid | Zhenyi Xue | Kimberly A Smith | T. P. Slottow
[1] Arianna Azzellino,et al. Randomized trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI). , 2007, Journal of the American College of Cardiology.
[2] J. Tijssen,et al. Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. , 2006, The New England journal of medicine.
[3] E. Bramucci,et al. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. , 2006, The New England journal of medicine.
[4] Barbara T. Unger,et al. Comparison of safety and efficacy of sirolimus-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction. , 2006, The American journal of cardiology.
[5] C. Xie,et al. Primary and rescue percutaneous coronary intervention with paclitaxel-eluting stent implantation in ST-elevation myocardial infarction. , 2006, American Journal of Cardiology.
[6] P. Serruys,et al. Sirolimus-eluting stents remain superior to bare-metal stents at two years: medium-term results from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. , 2006, Journal of the American College of Cardiology.
[7] K. Harjai,et al. Comparison of coronary stenting versus conventional balloon angioplasty on five-year mortality in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. , 2005, The American journal of cardiology.
[8] K. Kent,et al. Impact of sirolimus‐eluting stents on outcomes of patients treated for acute myocardial infarction by primary angioplasty , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[9] A. Santarelli,et al. Comparison of effectiveness of sirolimus-eluting stents versus bare metal stents for percutaneous coronary intervention in patients at high risk for coronary restenosis or clinical adverse events. , 2005, The American journal of cardiology.
[10] E. Regar,et al. Diabetic keto-acidosis and hyperkalaemia induced pseudo-myocardial infarction , 2005, Heart.
[11] R. Ferrari,et al. Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial. , 2005, JAMA.
[12] R. Gibbons,et al. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. , 2005, JAMA.
[13] M. Schwaiger,et al. A randomized trial of coronary stenting versus balloon angioplasty as a rescue intervention after failed thrombolysis in patients with acute myocardial infarction. , 2004, Journal of the American College of Cardiology.
[14] D. Baim,et al. Beyond Restenosis: Five-Year Clinical Outcomes From Second-Generation Coronary Stent Trials , 2004, Circulation.
[15] G. Gensini,et al. Early outcome after paclitaxel-eluting stents in patients with acute and subacute myocardial infarction. A clinical study. , 2004, Italian heart journal : official journal of the Italian Federation of Cardiology.
[16] D. Holmes,et al. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty. , 2004, American heart journal.
[17] P. Serruys,et al. Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction. , 2004, Journal of the American College of Cardiology.
[18] G. Stone,et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. , 2004, The New England journal of medicine.
[19] P. Serruys,et al. Sirolimus-Eluting Stent Implantation in ST-Elevation Acute Myocardial Infarction: A Clinical and Angiographic Study , 2003, Circulation.
[20] Jeffrey W Moses,et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. , 2003, The New England journal of medicine.
[21] J. J. Griffin,et al. Outcomes of optimal or "stent-like"balloon angioplasty in acutemyocardial infarction: the CADILLAC trial. , 2003, Journal of the American College of Cardiology.
[22] Patrick W. Serruys,et al. A randomized comparison of a sirolimus eluting stent with a standard stent for coronary revascularization , 2002 .
[23] P. Serruys,et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. , 2002, The New England journal of medicine.
[24] J. J. Griffin,et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. , 2002, The New England journal of medicine.
[25] W Rutsch,et al. Continued benefit of coronary stenting versus balloon angioplasty: five-year clinical follow-up of Benestent-I trial. , 2001, Journal of the American College of Cardiology.
[26] G. Stone,et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. , 2000, The New England journal of medicine.
[27] Bruce R. Brodie,et al. Coronary Angioplasty with or without Stent Implantation for Acute Myocardial Infarction , 1999 .